Diagnosis, Management and Prevention of Acute Hemolytic Anemia in Infants, Children and Adolescents

1.     Roper D, Layton M, Rees D, Lambert C, Vulliamy T, De la Salle B, D’Souza C, British Society for Haematology. Laboratory diagnosis of G6PD defciency. A British Society for Haematology Guideline. Br J Haematol. 2020. https://doi.org/10.1111/bjh.16366. PubMed PMID : 31991476.

2.     Frank JE (2005) Diagnosis and management of G6PD defciency. Am Fam Physician 72(7) :1277–1282 PubMed PMID : 16225031.

3.     Hill QA, Stamps R, Massey E, Grainger JD, Provan D, Hill A, British Society for Haematology (2017) The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol 176(3) :395–411. https://doi.org/10.1111/bjh.14478. PubMed PMID : 28005293.

4.     Ladogana S, Maruzzi M, Samperi P, Perrotta S, Del Vecchio GC, Notaran‑gelo LD et al (2017) Diagnosis and management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the Red Cell Study Group of the Paediatric Haemato-Oncology Italian Association. Blood Transfusion 15(3) :259. https://doi.org/10.2450/2016.0072-​16. PubMed. PMID : 28151390 ; PubMed Central PMCID PMCPMC5448833

5.     Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotlof K et al (2017) 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis 65(12) : e45-80. https://doi.org/10.1093/cid/cix959. PubMedPMID:291945. 9 ; PubMedCentralPMCID : PMCPMC5848254

6.     Bagga A, Khandelwal P, Mishra K, Thergaonkar R, Vasudevan A, Sharma J et al (2019) Hemolytic uremic syndrome in a developing country : consensus guidelines. Pediatr Nephrol 34 :1465–1482. https://doi.org/10.1007/s00467-​019-​04233-7

7.     Adamson JW, Longo DL. Anemia and polycythemia. In : Kasper DL, Harrison TR, editors. Harrison's principles of internal medicine. New York : McGraw-Hill, Medical Pub. Division ; 2005

8.     World Health O. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva : World Health Organization ; 2011.

9.     Dhaliwal G, Cornett PA, Tierney LM, Jr. Hemolytic anemia. Am Fam Physician. 2004 Jun 1 ;69(11) :2599-606. PubMed PMID : 15202694.

10.  Janz T, Hamilton G, editors. CHAPTER 121 Anemia, Polycythemia, and White Blood Cell Disorders2013.

11.  Barcellini W, Fattizzo B. Clinical Applications of Hemolytic Markers in the Differental Diagnosis and Management of Hemolytic Anemia. Dis Markers. 2015 ;2015 :635670. doi : 10.1155/2015/635670. PubMed PMID : 26819490 ; PubMed Central PMCID : PMCPMC4706896.

12.  Bain BJ. Diagnosis from the blood smear. N Engl J Med. 2005 Aug 4 ;353(5) :498-507. doi : 10.1056/NEJMra043442. PubMed PMID : 16079373.

13.  George JN, Charania RS. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia. Semin Thromb Hemost. 2013 Mar ;39(2) :153-60. doi: 10.1055/s-0032-1333538. PubMed PMID : 23390027.

14.  Baker KR, Moake J. Fragmentation Hemolytic Anemia. 2016. In : Williams hematology [Internet]. New York, N.Y. : McGraw-Hill Education LLC, 9th. [1 - 30 -online resource]. Available from: https://yale.idm.oclc.org/login?URL=https://accessmedicine.mhmedical.com/book. aspx ? bookID=1581.

15.  Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008 Jan 5 ;371(9606) :64-74. doi : 10.1016/S0140-6736(08)60073-2. PubMed PMID : 18177777.

16.  Kasemy ZA, Bahbah WA, El Hefnawy SM, et al. Prevalence of and mothers’ knowledge, attitude and practice towards glucose-6-phosphate dehydrogenase deficiency among neonates with jaundice : a cross-sectional study BMJ Open 2020 ;10 : e034079. doi : 10.1136/bmjopen-2019-034079.

17.  Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002 Apr ;69(4) :258-71. doi : 10.1002/ajh.10062. PubMed PMID : 11921020.

18.  Packman CH. Hemolytic Anemia Resulting from Immune Injury. 2016. In : Williams hematology [Internet]. New York, N.Y. : McGraw-Hill Education LLC, 9th. [1 online resource]. Available from: https://yale.idm.oclc.org/login?URL=https://accessmedicine.mhmedical.com/book. aspx?bookID=1581.

19.  Bunn HF, Rosse W. Hemolytic anemias and acute blood loss. In : Kasper DL, Harrison TR, Fauci AS, et al., editors. Harrison's Principles of Internal Medicine : McGraw-Hill, Medical Pub. Division ; 2005.

20.  Packman CH. Hemolytic anemia due to warm autoantibodies. Blood reviews. 2008 Jan ;22(1) :17-31. doi : 10.1016/j.blre.2007.08.001. PubMed PMID : 17904259 ; eng.

21.  Petz LD. Emergency Transfusion Guidelines for Autoimmune Hemolytic Anemia. Laboratory Medicine. 2005 ;36(1) :45-48. doi : 10.1309/NE3BH8U3K6N1149V %J Laboratory Medicine.

22.  Siegler R, Oakes R. Hemolytic uremic syndrome ; pathogenesis, treatment, and outcome. Curr Opin Pediatr. 2005 Apr ;17(2) :200-4. doi : 10.1097/01.mop.0000152997. 66070.e9. PubMed PMID : 15800412.

23.  Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005 Mar 19-25 ;365(9464) :1073-86. doi : 10.1016/S0140-6736(05)71144-2. PubMed PMID : 15781103.

24.  Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and outcome of Shiga toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol. 2008 Oct ;23(10) :1749-60. doi : 10.1007/s00467-008-0935-6. PubMed PMID : 18704506 ; PubMed Central PMCID : PMCPMC6901419.

25.  Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol. Dec 2010;63(12):1308-11. doi:10.1016/j.jclinepi.2010.07.001

26.  Song Y, Alonso-Coello P, Ballesteros M, et al. A Reporting Tool for Adapted Guidelines in Health Care: The RIGHT-Ad@pt Checklist. Ann Intern Med. May 2022;175(5):710-719. doi:10.7326/m21-4352

27.  AGREE Tools. The AGREE Research Trust. 2024. www.agreetrust.org

28.  Abdel Baky A, Omar TEI, Amer YS, the Egyptian Pediatric Clinical Practice Guidelines C. Adapting global evidence-based practice guidelines to the Egyptian healthcare context: the Egyptian Pediatric Clinical Practice Guidelines Committee (EPG) initiative. Bulletin of the National Research Centre. 2023/06/13 2023;47(1):88. doi:10.1186/s42269-023-01059-0

29.  Alshehri A, Almazrou S, Amer Y. Methodological frameworks for adapting global practice guidelines to national context in the Eastern Mediterranean Region. East Mediterr Health J. Jul 31 2023;29(7):540-553. doi:10.26719/emhj.23.070

30.  Amer YS, Elzalabany MM, Omar TI, Ibrahim AG, Dowidar NL. The 'Adapted ADAPTE': an approach to improve utilization of the ADAPTE guideline adaptation resource toolkit in the Alexandria Center for Evidence-Based Clinical Practice Guidelines. Journal of evaluation in clinical practice. Dec 2015;21(6):1095-106. doi:10.1111/jep.12479

31.  Klugar M, Lotfi T, Darzi AJ, et al. GRADE guidance 39: using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses. J Clin Epidemiol. Aug 6 2024;174:111494. doi:10.1016/j.jclinepi.2024.111494

32.  Luzzatto L, Seneca E. G6PD deficiency : a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol. 2014 Feb ;164(4) :469-80. doi : 10.1111/bjh.12665. PubMed PMID : 24372186 ; PubMed Central PMCID : PMCPMC4153881.

33.  Bagga A, Khandelwal P, Mishra K, et al. Hemolytic uremic syndrome in a developing country : Consensus guidelines. Pediatr Nephrol. 2019 Aug ;34(8) :1465-1482. doi : 10.1007/s00467-019-04233-7. PubMed PMID : 30989342.